SCHEMBL5033181

SCHEMBL5033181

CC(C)(O)Nc1nc(Sc2nnsc2Cl)nc2[nH]c(=O)sc12

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 13/20 0.35
CX3CR1 P49238 9/20 0.34
HTR1B P28222 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12022718 0.55 CXCR2 (0.71) CXCR2CX3CR1HTR1B
SCHEMBL213575 0.55 CXCR2 (0.62) CXCR2CX3CR1HTR1B
SCHEMBL8663220 0.53 RPS6KA3 (0.32)
SCHEMBL8124140 0.53
SCHEMBL17904270 0.48 RPS6KA3 (0.37) CXCR2
SCHEMBL12281708 0.46
SCHEMBL9732756 0.44 LMNA (0.46)
SCHEMBL8664696 0.41 LIMK1 (0.39)
SCHEMBL23214568 0.40
SCHEMBL21720492 0.40

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1348709-B1 Thiazolo[4,5-d]pyrimidine compounds for the treatment of rheumatoid arthritis ASTRAZENECA UK LTD (GB) 2008-01-16 EP disclosed